Back to Search
MARISOL SCHUTTE, PHARMD
PHARMD
Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
NPI: 1588202683Individual
Specialties, Licenses & Credentials
Pharmacist Clinician (PhC)/ Clinical Pharmacy SpecialistPrimary
Pharmacist — Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
Code: 1835P0018X
26021316A(IN)
Research & Publications (20)
Quercetin increases the bioavailability of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rats.
PMID 18783729·Food Chem Toxicol·2008
7-preclinical
Effects of flavonoid mixtures on the transport of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) through Caco-2 monolayers: an in vitro and kinetic modeling approach to predict the combined effects on transporter inhibition.
PMID 17935851·Food Chem Toxicol·2008
8-other
An in vitro and in silico study on the flavonoid-mediated modulation of the transport of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) through Caco-2 monolayers.
PMID 16997339·Toxicol Appl Pharmacol·2006
8-other
Myricetin stimulates the absorption of the pro-carcinogen PhIP.
PMID 16356829·Cancer Lett·2006
8-other
Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines.
PMID 19593635·Breast Cancer Res Treat·2010
8-other
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.
PMID 19330027·Nat Genet·2009
8-other
Low-risk susceptibility alleles in 40 human breast cancer cell lines.
PMID 19607694·BMC Cancer·2009
8-other
Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells.
PMID 19116383·J Natl Cancer Inst·2009
8-other
CHEK2 1100delC and male breast cancer in the Netherlands.
PMID 18759107·Breast Cancer Res Treat·2009
8-other
Deleterious CHEK2 1100delC and L303X mutants identified among 38 human breast cancer cell lines.
PMID 18297428·Breast Cancer Res Treat·2009
8-other
CHEK2 1100delC is a susceptibility allele for HNPCC-related colorectal cancer.
PMID 18676774·Clin Cancer Res·2008
8-other
MDM2 SNP309 accelerates familial breast carcinogenesis independently of estrogen signaling.
PMID 17080308·Breast Cancer Res Treat·2007
8-other
Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines.
PMID 17314276·Mol Cancer Res·2007
8-other
BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants.
PMID 16397213·Cancer Res·2006
8-other
A multicenter study of cancer incidence in CHEK2 1100delC mutation carriers.
PMID 17164383·Cancer Epidemiol Biomarkers Prev·2006
4-observational
Association between the CHEK2*1100delC germ line mutation and estrogen receptor status.
PMID 17010071·Int J Gynecol Cancer·2006
4-observational
Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients.
PMID 16978825·Biomed Pharmacother·2006
6-review
Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines.
PMID 16541312·Breast Cancer Res Treat·2006
8-other
Representational difference analysis as a tool in the search for new tumor suppressor genes.
PMID 15542904·Methods Mol Med·2005
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1034 STATE ROAD 229
BATESVILLE, IN 47006 - Phone
- (812) 933-6220
Quick Facts
- NPI
- 1588202683
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile